Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Influence of viral infections on allografts function and acute graft rejection (agr) in both donors and recipients

P Jurkowski, A Mikłaszewicz, M Cićkiewicz, P Orszulak, M Fiedor, Z Lewandowski, P Fiedor

Ann Transplant 2009; 14(1): 74-74 :: ID: 880471

Abstract

Background: Virus infections play a key role and directly influence allograft
function in recipients under chronic immunosuppression. The aim of this study was to evaluate the infl uence of CMV, EBV, HBV and HCV virus infections in both donors and recipients on graft stability.
Material/Methods: The medical histories of 171 kidney and liver allograft recipients were analyzed in search of viral infections. Next, every recipient was matched with their donors. It was evaluated how different viral infections influence the time of acute graft rejection.
Results: There was no significant difference in the time of acute rejection time between HBVAg positive and HBVAg negative recipients (p>0.05). Seven months after transplantation, the number of Anti-HCV positive recipients after AGR was twice as big as the number of Anti-HCV negative patients (p=0.0176). Seven months after transplantation, the number of CMV-IgM positive recipients after AGR was three times as big as the number of CMV-IgM negative patients(p=0.0292). There was found no correlation between EBV infection and acute rejection time.
Conclusions: Our data strongly indicate that both HCV and CMV virus infections worsen allograft stability in transplant recipients and immunosuppression is an independent risk factor.

Keywords: CMV infections, HBV infection, HCV infection, viral infections

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358